Lardennois, A.; Duda, V.; Dingare, C.; Klemmt, P. A.; Heinzen, C.; Desruelles, L.; Heyde, M.; Kleinhans, D. S.; Falk, T.; Schelmbauer, C.et al.; Mozolewska, O.; Papadopoulou, S.; Lai, J. J. K.; Stainier, D. Y. R.; Lecaudey, V.: Two distinct modes of Vgll4-mediated Tead regulation control organ size in zebrafish. COMMUNICATIONS BIOLOGY 9 (1), 574 (2026)
Researchers at the Max Planck Institute develop a new pharmacological approach that specifically targets receptor interactions – with implications for immune defense and blood pressure regulation
A team of researchers at the Max Planck Institute for Heart and Lung Research, led by Prof. Dr. Didier Y.R. Stainier, has been awarded a prestigious ERC Proof of Concept (PoC) grant to advance a groundbreaking RNA-based therapeutic strategy for Duchenne Muscular Dystrophy (DMD).